ProductProductWhat are Generics?
Diovan
view photo
Generic Diovan Valsartan 40/80/160mg

Generic Diovan is used for treating high blood pressure alone or with other medicines. It is also used for treating heart failure in patients who do not tolerate angiotensin-converting enzyme (ACE) inhibitors.


Hypertension, Cardiovascular Diseases


PackagePricePer pillSavingsOrder
40mg × 30 pills$45.00$ 1.50 
40mg × 60 pills$85.00$ 1.42  $5.00
40mg × 90 pills$115.00$ 1.28  $20.00
40mg × 120 pills$145.00$ 1.21  $35.00
40mg × 180 pills$216.00$ 1.20  $54.00
PackagePricePer pillSavingsOrder
80mg × 30 pills$55.00$ 1.83 
80mg × 60 pills$105.00$ 1.75  $5.00
80mg × 90 pills$145.00$ 1.61  $20.00
80mg × 120 pills$185.00$ 1.54  $35.00
80mg × 180 pills$255.00$ 1.42  $75.00
PackagePricePer pillSavingsOrder
160mg × 30 pills$61.13$ 2.04 
160mg × 60 pills$117.51$ 1.96  $4.75
160mg × 90 pills$173.95$ 1.93  $9.44
160mg × 120 pills$228.85$ 1.91  $15.67
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
Many thanks, yes I have received my full order. I have used other internet suppliers but you are the best of the best ! Thank you again for a brilliant product & service. - Kindest regards, Rod
Read more »Read more »
NewsNews
    Novartis Quarterly Profit Drops as Diovan, OTC Sales Slump - BusinessWeek
    AFPNovartis Quarterly Profit Drops as Diovan, OTC Sales SlumpBusinessWeekChief Executive Officer Joe Jimenez is facing the loss of billions in revenue as the company's top-selling drug, Diovan, loses patent protection this year
    Novartis Profit Hit by Diovan - Wall Street Journal
    BloombergNovartis Profit Hit by DiovanWall Street JournalBy MARTA FALCONI ZURICH—Swiss drug maker Novartis AG said Tuesday that net profit declined 16
    Novartis to Buy Fougera for $1.5 Billion for Skin Drugs - Bloomberg
    BloombergNovartis to Buy Fougera for $1
    Novartis Sues Lupin, Torrent Over Blood-Pressure Medicine - Bloomberg
    Novartis Sues Lupin, Torrent Over Blood-Pressure MedicineBloombergNovartis, based in Basel, Switzerland, is counting on new products, including Exforge, to help replace revenue lost when the company's best sellers, Diovan for hypertension and Gleevac for leukemia, start to lose US patent protection later this year
    Pernod Ricard, Kodak, Apple, Novartis: Intellectual Property - BusinessWeek
    Pernod Ricard, Kodak, Apple, Novartis: Intellectual PropertyBusinessWeekNovartis, based in Basel, Switzerland, is counting on new products, including Exforge, to help replace revenue lost when the company's best sellers, Diovan for hypertension and Gleevac for leukemia, start to lose US patent protection later this year
Live support Online Chat


Our billing is certified by
Secure shopping certificates